ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,430,295 | -63.6% | 528,325 | -48.9% | 0.00% | -100.0% |
| Q2 2023 | $6,681,617 | +21.3% | 1,034,306 | +41.5% | 0.00% | 0.0% |
| Q1 2023 | $5,509,772 | -42.7% | 730,739 | -23.0% | 0.00% | -50.0% |
| Q4 2022 | $9,614,474 | -65.8% | 949,109 | -66.6% | 0.00% | -71.4% |
| Q3 2022 | $28,093,000 | +14.8% | 2,840,544 | +23.6% | 0.01% | +16.7% |
| Q2 2022 | $24,475,000 | +706.7% | 2,298,200 | +638.7% | 0.01% | – |
| Q1 2022 | $3,034,000 | -87.0% | 311,112 | -80.9% | 0.00% | – |
| Q4 2021 | $23,322,000 | -5.0% | 1,630,826 | +33.2% | 0.00% | -100.0% |
| Q3 2021 | $24,545,000 | +64.5% | 1,224,780 | +80.6% | 0.00% | +50.0% |
| Q2 2021 | $14,923,000 | +366.5% | 678,326 | +620.1% | 0.00% | – |
| Q1 2021 | $3,199,000 | +88.4% | 94,200 | +123.3% | 0.00% | – |
| Q4 2020 | $1,698,000 | – | 42,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |